. . . . . . . . "ABSTRAL® is indicated for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving, and who are tolerant to, around-the-clock opioid therapy for their underlying persistent cancer pain." . . . "NeuroDKG" . . . "cancer patients 18 years of age and older who are already receiving, and who are tolerant to, around-the-clock opioid therapy for their underlying persistent cancer pain" . "18" . . . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "KDxCEQgTVz+3euJPPQludpB26SPYwtqnb9Pqdch5GxDKyoM9wvVJbvhwJJn/jHp9gRg+gT0fajxiAbb63rxwLykXoYS1dn3JWjtv8eQsIQpSiSEqmIDwTZSo/oTUe0g0iiPVnpkiBILk1DfnTEBATLraqgmK1FNZ3bct77uveM4=" . . "2021-03-28T20:19:13.984+02:00"^^ . . . . .